Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Learn about the dangers of holding cash. This guide will help you understand the potential risks involved with cash savings.
18,190 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Nvidia is fueling a bold thesis for H2 2026 as AI infrastructure demand climbs. With data-center momentum and locked-...
A bitcoin miners ETF posted a dramatic weekly surge, underscoring how mining infrastructure can deliver cash flows ev...
Micron Technology faces a pivotal moment as AI memory demand accelerates. Analysts weigh a potential multi-year upcyc...
Political discussions around Social Security could reshape retirement planning. This article breaks down what the Spe...
As AI workloads expand, data center power stocks are seeing a fresh wave of orders and upgraded guidance. This report...
Nike's quarterly results offer more than sneaker news. This guide breaks down the numbers, the stock reaction, and ac...
Beazer Homes faces a pivotal moment as Dream Finders increases its cash bid to $32 per share, intensifying the beazer...
As American Express prepares to report earnings, the key question is how its card-fee growth stacks up against spendi...
GE Vernova arrives at its July 22 earnings with a $163 billion backlog and raised targets, signaling a strong beat ri...
AI growth hinges on advanced chips, and Taiwan Semiconductor Manufacturing sits at the center. This article breaks do...
Apple rides a fresh all-time high as HSBC analysts turn bullish, lifting targets and signaling more upside. Services ...